APO RESEARCH · REPORT
Cyclodextrin in Pharma
Cyclodextrins are a family of cyclic oligosaccharides, consisting of a macrocyclic ring of glucose subunits joined by α-1,4 glycosidic bonds. Cyclodextrins are produced from starch by enzymatic conversion. They are used in food, pharmaceutical, drug delivery, and chemical industries, as well as agriculture and environmental engineering.
Product & engineering
Understand the product.
Cyclodextrins are a family of cyclic oligosaccharides, consisting of a macrocyclic ring of glucose subunits joined by α-1,4 glycosidic bonds. Cyclodextrins are produced from starch by enzymatic conversion. They are used in food, pharmaceutical, drug delivery, and chemical industries, as well as agriculture and environmental engineering.
Selected research
Industry Research
Cyclodextrin in Pharma Industry Research Report 2026
Market perspective
Cyclodextrins are a family of cyclic oligosaccharides, consisting of a macrocyclic ring of glucose subunits joined by α-1,4 glycosidic bonds. Cyclodextrins are produced from starch by enzymatic conversion. They are used in food, pharmaceutical, drug delivery, and chemical industries, as well as agriculture and environmental engineering.
Global key manufacturers of cyclodextrin in pharma include Wacker, Ensuiko Sugar Refining, Ashland, etc. Global top 3 manufacturers hold a share above 60%. Europe and North America are the major producing regions in the world, followed by China and Japan. In terms of application, the product is most widely used in tablets and capsules, followed by injectables.
Report Scope
Read the full market overview
This report quantifies the global Cyclodextrin in Pharma market in revenue (US$ million) and, where applicable, sales volume (MT), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/MT) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Cyclodextrin in Pharma.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cyclodextrin in Pharma Market by Company
Wacker
Ensuiko Sugar Refining
Nihon Shokuhin Kako
Roquette
Ashland
Shandong Xinda
Yunan Yongguang
Qufu Tianli
Zibo Qianhui
Jiangsu Fengyuan
Mengzhou Huaxing
Mengzhou Hongji
Cyclodextrin in Pharma Segment by Type
Alpha-Cyclodextrin in Pharma
Beta-Cyclodextrin in Pharma
Gamma-Cyclodextrin in Pharma
CD Derivatives
Cyclodextrin in Pharma Segment by Application
Tablets and Capsules
Injectables
Cyclodextrin in Pharma Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyclodextrin in Pharma market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cyclodextrin in Pharma and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyclodextrin in Pharma.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cyclodextrin in Pharma manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cyclodextrin in Pharma by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cyclodextrin in Pharma in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Alpha-Cyclodextrin in Pharma
- Beta-Cyclodextrin in Pharma
- Gamma-Cyclodextrin in Pharma
- CD Derivatives
Applications
- Tablets and Capsules
- Injectables
Companies covered
- Wacker
- Ensuiko Sugar Refining
- Nihon Shokuhin Kako
- Roquette
- Ashland
- Shandong Xinda
- Yunan Yongguang
- Qufu Tianli
- Zibo Qianhui
- Jiangsu Fengyuan
- Mengzhou Huaxing
- Mengzhou Hongji
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Cyclodextrin in Pharma by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Alpha-Cyclodextrin in Pharma
- 2.2.3 Beta-Cyclodextrin in Pharma
- 2.2.4 Gamma-Cyclodextrin in Pharma
- 2.2.5 CD Derivatives
- 2.3 Cyclodextrin in Pharma by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablets and Capsules
- 2.3.3 Injectables
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Cyclodextrin in Pharma Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Cyclodextrin in Pharma Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Cyclodextrin in Pharma Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Cyclodextrin in Pharma Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cyclodextrin in Pharma Production by Manufacturers (2021-2026)
- 3.2 Global Cyclodextrin in Pharma Production Value by Manufacturers (2021-2026)
- 3.3 Global Cyclodextrin in Pharma Average Price by Manufacturers (2021-2026)
- 3.4 Global Cyclodextrin in Pharma Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Cyclodextrin in Pharma Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Cyclodextrin in Pharma Manufacturers, Product Type & Application
- 3.7 Global Cyclodextrin in Pharma Manufacturers Established Date
- 3.8 Global Cyclodextrin in Pharma Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Wacker
- 4.1.1 Wacker Cyclodextrin in Pharma Company Information
- 4.1.2 Wacker Cyclodextrin in Pharma Business Overview
- 4.1.3 Wacker Cyclodextrin in Pharma Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Wacker Product Portfolio
- 4.1.5 Wacker Recent Developments
- 4.2 Ensuiko Sugar Refining
- 4.2.1 Ensuiko Sugar Refining Cyclodextrin in Pharma Company Information
- 4.2.2 Ensuiko Sugar Refining Cyclodextrin in Pharma Business Overview
- 4.2.3 Ensuiko Sugar Refining Cyclodextrin in Pharma Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Ensuiko Sugar Refining Product Portfolio
- 4.2.5 Ensuiko Sugar Refining Recent Developments
- 4.3 Nihon Shokuhin Kako
- 4.3.1 Nihon Shokuhin Kako Cyclodextrin in Pharma Company Information
- 4.3.2 Nihon Shokuhin Kako Cyclodextrin in Pharma Business Overview
- 4.3.3 Nihon Shokuhin Kako Cyclodextrin in Pharma Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Nihon Shokuhin Kako Product Portfolio
- 4.3.5 Nihon Shokuhin Kako Recent Developments
- 4.4 Roquette
- 4.4.1 Roquette Cyclodextrin in Pharma Company Information
- 4.4.2 Roquette Cyclodextrin in Pharma Business Overview
- 4.4.3 Roquette Cyclodextrin in Pharma Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Roquette Product Portfolio
- 4.4.5 Roquette Recent Developments
- 4.5 Ashland
- 4.5.1 Ashland Cyclodextrin in Pharma Company Information
- 4.5.2 Ashland Cyclodextrin in Pharma Business Overview
- 4.5.3 Ashland Cyclodextrin in Pharma Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Ashland Product Portfolio
- 4.5.5 Ashland Recent Developments
- 4.6 Shandong Xinda
- 4.6.1 Shandong Xinda Cyclodextrin in Pharma Company Information
- 4.6.2 Shandong Xinda Cyclodextrin in Pharma Business Overview
- 4.6.3 Shandong Xinda Cyclodextrin in Pharma Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Shandong Xinda Product Portfolio
- 4.6.5 Shandong Xinda Recent Developments
- 4.7 Yunan Yongguang
- 4.7.1 Yunan Yongguang Cyclodextrin in Pharma Company Information
- 4.7.2 Yunan Yongguang Cyclodextrin in Pharma Business Overview
- 4.7.3 Yunan Yongguang Cyclodextrin in Pharma Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Yunan Yongguang Product Portfolio
- 4.7.5 Yunan Yongguang Recent Developments
- 4.8 Qufu Tianli
- 4.8.1 Qufu Tianli Cyclodextrin in Pharma Company Information
- 4.8.2 Qufu Tianli Cyclodextrin in Pharma Business Overview
- 4.8.3 Qufu Tianli Cyclodextrin in Pharma Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Qufu Tianli Product Portfolio
- 4.8.5 Qufu Tianli Recent Developments
- 4.9 Zibo Qianhui
- 4.9.1 Zibo Qianhui Cyclodextrin in Pharma Company Information
- 4.9.2 Zibo Qianhui Cyclodextrin in Pharma Business Overview
- 4.9.3 Zibo Qianhui Cyclodextrin in Pharma Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Zibo Qianhui Product Portfolio
- 4.9.5 Zibo Qianhui Recent Developments
- 4.10 Jiangsu Fengyuan
- 4.10.1 Jiangsu Fengyuan Cyclodextrin in Pharma Company Information
- 4.10.2 Jiangsu Fengyuan Cyclodextrin in Pharma Business Overview
- 4.10.3 Jiangsu Fengyuan Cyclodextrin in Pharma Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Jiangsu Fengyuan Product Portfolio
- 4.10.5 Jiangsu Fengyuan Recent Developments
- 4.11 Mengzhou Huaxing
- 4.11.1 Mengzhou Huaxing Cyclodextrin in Pharma Company Information
- 4.11.2 Mengzhou Huaxing Cyclodextrin in Pharma Business Overview
- 4.11.3 Mengzhou Huaxing Cyclodextrin in Pharma Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 Mengzhou Huaxing Product Portfolio
- 4.11.5 Mengzhou Huaxing Recent Developments
- 4.12 Mengzhou Hongji
- 4.12.1 Mengzhou Hongji Cyclodextrin in Pharma Company Information
- 4.12.2 Mengzhou Hongji Cyclodextrin in Pharma Business Overview
- 4.12.3 Mengzhou Hongji Cyclodextrin in Pharma Production Capacity, Value and Gross Margin (2021-2026)
- 4.12.4 Mengzhou Hongji Product Portfolio
- 4.12.5 Mengzhou Hongji Recent Developments
5 Global Cyclodextrin in Pharma Production by Region
- 5.1 Global Cyclodextrin in Pharma Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cyclodextrin in Pharma Production by Region: 2021-2032
- 5.2.1 Global Cyclodextrin in Pharma Production by Region: 2021-2026
- 5.2.2 Global Cyclodextrin in Pharma Production Forecast by Region (2027-2032)
- 5.3 Global Cyclodextrin in Pharma Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Cyclodextrin in Pharma Production Value by Region: 2021-2032
- 5.4.1 Global Cyclodextrin in Pharma Production Value by Region: 2021-2026
- 5.4.2 Global Cyclodextrin in Pharma Production Value Forecast by Region (2027-2032)
- 5.5 Global Cyclodextrin in Pharma Market Price Analysis by Region (2021-2026)
- 5.6 Global Cyclodextrin in Pharma Production and Value, YOY Growth
- 5.6.1 North America Cyclodextrin in Pharma Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Cyclodextrin in Pharma Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Cyclodextrin in Pharma Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Cyclodextrin in Pharma Production Value Estimates and Forecasts (2021-2032)
6 Global Cyclodextrin in Pharma Consumption by Region
- 6.1 Global Cyclodextrin in Pharma Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Cyclodextrin in Pharma Consumption by Region (2021-2032)
- 6.2.1 Global Cyclodextrin in Pharma Consumption by Region: 2021-2026
- 6.2.2 Global Cyclodextrin in Pharma Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Cyclodextrin in Pharma Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Cyclodextrin in Pharma Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Cyclodextrin in Pharma Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Cyclodextrin in Pharma Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Cyclodextrin in Pharma Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Cyclodextrin in Pharma Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Cyclodextrin in Pharma Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Cyclodextrin in Pharma Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Cyclodextrin in Pharma Production by Type (2021-2032)
- 7.1.1 Global Cyclodextrin in Pharma Production by Type (2021-2032) & (MT)
- 7.1.2 Global Cyclodextrin in Pharma Production Market Share by Type (2021-2032)
- 7.2 Global Cyclodextrin in Pharma Production Value by Type (2021-2032)
- 7.2.1 Global Cyclodextrin in Pharma Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Cyclodextrin in Pharma Production Value Market Share by Type (2021-2032)
- 7.3 Global Cyclodextrin in Pharma Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Cyclodextrin in Pharma Production by Application (2021-2032)
- 8.1.1 Global Cyclodextrin in Pharma Production by Application (2021-2032) & (MT)
- 8.1.2 Global Cyclodextrin in Pharma Production Market Share by Application (2021-2032)
- 8.2 Global Cyclodextrin in Pharma Production Value by Application (2021-2032)
- 8.2.1 Global Cyclodextrin in Pharma Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Cyclodextrin in Pharma Production Value Market Share by Application (2021-2032)
- 8.3 Global Cyclodextrin in Pharma Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Cyclodextrin in Pharma Value Chain Analysis
- 9.1.1 Cyclodextrin in Pharma Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Cyclodextrin in Pharma Production Mode & Process
- 9.2 Cyclodextrin in Pharma Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Cyclodextrin in Pharma Distributors
- 9.2.3 Cyclodextrin in Pharma Customers
10 Global Cyclodextrin in Pharma Analyzing Market Dynamics
- 10.1 Cyclodextrin in Pharma Industry Trends
- 10.2 Cyclodextrin in Pharma Industry Drivers
- 10.3 Cyclodextrin in Pharma Industry Opportunities and Challenges
- 10.4 Cyclodextrin in Pharma Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst